CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)

Stephen D. Skaper  
Department of Pharmaceutical and Pharmacological Sciences
University of Padova


Kynurenine Pathway and Disease: An Overview

Author(s): Abel Santamaria, Veronica Perez-De La Cruz and Mina Konigsberg

Affiliation: Laboratorio de Aminoacidos Excitadores, Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, Insurgentes Sur 3877, Mexico D.F. 14269, Mexico.


Kynurenine pathway is gaining more and more attention every day in biomedical research since this catabolic route for tryptophan decomposition is not only implicated in different neurological disorders, but also possesses neuroactive metabolites with different biological properties, such as pro-oxidant and antioxidant regulators. Thus, the intensive research on this metabolic pathway is helping us to understand those mechanisms underlying neurodegenerative events during the occurrence of pathological process in the central nervous system (CNS), thereby allowing the design of potential therapies for those disorders involving excitotoxic, oxidative and inflammatory components. Here we intend to provide a brief overview on the relevance of this route for several CNS disorders, and discuss recent information on the different biological properties of the neuroactive metabolites of this pathway and their significance for further research.

Keywords: Kynurenines, thryptophan metabolism, central nervous system, neurotoxicity, disease

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

Page: [398 - 410]
Pages: 13
DOI: 10.2174/187152707783399229
Price: $58